Leukocyte telomere length is associated with survival and drug resistance in lung adenocarcinoma patients treated with EGFR-TKIs

被引：0
|
作者：
Yang, M. [1 ]
Li, J. [1 ]
Zhang, N. [2 ]
机构：
[1] Shandong Canc Hosp, Canc Res Ctr, Shandong Prov Key Lab Radiat Oncol, Jinan, Shandong, Peoples R China
[2] Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
10.1093/annonc/mdy318.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Leukocyte telomere length and recurrence risk after EGFR-TKIs therapy in patients with advanced lung adenocarcinoma
    Yang, M.
    Li, J.
    Zhang, N.
    Xing, H.
    Liu, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
    Lin, Jessica J.
    Cardarella, Stephanie
    Lydon, Christine A.
    Dahlberg, Suzanne E.
    Jackman, David M.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : 556 - 565
  • [3] Continued EGFR-TKIs treatment promotes the survival of elderly patients with acquired resistance to EGFR-TKIs therapy
    Wang, P.
    Zhang, D.
    Li, X. -M.
    Guo, X. -G.
    Sun, B. -J.
    Fang, X. -Q.
    Qu, G. -P.
    An, L.
    Liu, C. -T.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (11) : 2450 - 2459
  • [4] THE RESISTANCE TO EGFR-TKIS IN LUNG CANCER
    Yamada, T.
    Yano, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [5] Prognostic Factors in Lung Adenocarcinoma with Bone Metastasis Treated with EGFR-TKIs
    Chiu, Tzu-Hsuan
    Lin, Chun-Yu
    Hsieh, Meng-Heng
    Lin, Shu-Min
    Fang, Yueh-Fu
    [J]. MEDICINA-LITHUANIA, 2021, 57 (09):
  • [6] Use of iTRAQ to discover serum proteins associated with acquired EGFR-TKIs resistance in patients with advanced lung adenocarcinoma
    Xu, Yufen
    Chen, Wenyu
    Li, Xia
    Jiang, Yiming
    Song, Binbin
    Zhou, Qiang
    Wang, Aifen
    Wang, Yajuan
    Yang, Xinmei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4210 - 4220
  • [7] METFORMIN PROLONGS SURVIVAL IN LUNG CANCER EGFR-TKIS PATIENTS
    Hung, Ming-Szu
    Chuang, Min-Chun
    Yang, Yao-Hsu
    Lung, Jrhau
    Tsai, Ying-Huang
    [J]. RESPIROLOGY, 2018, 23 : 171 - 171
  • [8] Role of GPER1 in the Mechanism of EGFR-TKIs Resistance in Lung Adenocarcinoma
    Li, Zhenhua
    Pan, Yaqiang
    Liu, Qinghua
    Wang, Jian
    Liu, Chang
    Qu, Laihao
    Li, Dingbiao
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] EGFR-TKIs compared with radiotherapy for patients of stage IV lung adenocarcinoma with EGFR mutation
    Wang, Y.
    Yu, W.
    Shi, J.
    Qiu, M.
    Jiang, N.
    Wang, Z.
    Yang, J.
    Song, M.
    Jia, Z.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S976 - S976
  • [10] The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs
    He, Qiong
    Li, Yamin
    Zhou, Xihong
    Zhou, Wen
    Xia, Chunfang
    Zhang, Ruzhe
    Zhang, Zhengjie
    Hu, Aiyang
    Peng, Siyin
    Li, Jing
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (04)
12345